Since MYC is frequently over-expressed in BC, this phenomenon could play a critical role in BCR/ABL1 up-regulation and blast aggressiveness acquired during CML evolution. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.